SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001078782-20-001012
Filing Date
2020-12-28
Accepted
2020-12-28 12:38:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 13g122820_sc13g.htm SC 13G 45495
  Complete submission text file 0001078782-20-001012.txt   47328
Mailing Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022
Business Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022 917-796-9926
TAURIGA SCIENCES, INC. (Subject) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-87657 | Film No.: 201416771
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 110 WALL STREET SUITE 5-070 NEW YORK NY 10005
Business Address 110 WALL STREET SUITE 5-070 NEW YORK NY 10005 212-419-8202
GS Capital Partners, LLC (Filed by) CIK: 0001720125 (see all company filings)

IRS No.: 821042853 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G